<DOC>
	<DOCNO>NCT00897507</DOCNO>
	<brief_summary>RATIONALE : DNA analysis tumor tissue may help doctor predict well patient respond treatment PURPOSE : This laboratory study look DNA tumor tissue sample young patient acute lymphoblastic leukemia .</brief_summary>
	<brief_title>DNA Analysis Tumor Tissue Samples From Young Patients With Acute Lymphoblastic Leukemia</brief_title>
	<detailed_description>OBJECTIVES : Primary - Determine role single nucleotide polymorphism ( SNPs ) determine response therapy pediatric patient acute lymphoblastic leukemia . Secondary - Compare association SNPs treatment outcome toxicity patient enrol protocol CCG-1891 v protocol CCG-1952 . - Determine role SNPs drug metabolize enzyme development veno-occlusive disease patient enrol CCG-1952 . - Evaluate interaction genotype risk factor treatment response patient . - Determine predictive model utilize genetic information clinical data predict treatment response toxicity patient . OUTLINE : Tumor tissue sample undergo genotype assessment Pyrosequencing platform . Contingency table X^2 test performs univariate analysis risk relapse genotype , multivariable analysis use logistic regression . Cox proportional hazard evaluate risk relapse give genotype confounders . Genotype patterning , classification regression tree , multifactor dimensionality reduction evaluate pattern single nucleotide polymorphisms associate toxicity relapse risk . PROJECTED ACCRUAL : A total 800 patient ( 200 relapse disease 600 without relapsed disease ) accrue study .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Enrolled clinical trial CCG1891 CCG1952 PATIENT CHARACTERISTICS : Age Under 18 Performance status Not specify Life expectancy Not specify Hematopoietic Not specify Hepatic Not specify Renal Not specify PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy Not specify Endocrine therapy Not specify Radiotherapy Not specify Surgery Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>childhood acute lymphoblastic leukemia remission</keyword>
	<keyword>recurrent childhood acute lymphoblastic leukemia</keyword>
</DOC>